Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA.
Ottaviano M, Giuliano M, Tortora M, La Civita E, Liotti A, Longo M, Bruzzese D, Cennamo M, Riccio V, De Placido P, Picozzi F, Parola S, Daniele B, Botti G, Formisano P, Beguinot F, De Placido S, Terracciano D, Palmieri G. Ottaviano M, et al. Among authors: giuliano m. Front Oncol. 2021 Feb 4;10:602153. doi: 10.3389/fonc.2020.602153. eCollection 2020. Front Oncol. 2021. PMID: 33634024 Free PMC article.
Immunological signature of patients with thymic epithelial tumors and Good syndrome.
Malfitano AM, D'Esposito V, De Placido P, Tortora M, Ottaviano M, Pietroluongo E, Morra R, Mucci B, Napolitano F, Montella L, Giuliano M, De Placido S, Terracciano D, Palmieri G, Formisano P. Malfitano AM, et al. Among authors: giuliano m. Front Immunol. 2022 Aug 18;13:908453. doi: 10.3389/fimmu.2022.908453. eCollection 2022. Front Immunol. 2022. PMID: 36059463 Free PMC article.
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study.
De Placido P, Pietroluongo E, De Angelis C, Tafuro M, Barraco C, Giannatiempo R, Buonaiuto R, Schettini F, Iervolino A, Vozzella EA, Giuliano M, Bianco R, Arpino G. De Placido P, et al. Among authors: giuliano m. Front Oncol. 2022 Aug 19;12:951026. doi: 10.3389/fonc.2022.951026. eCollection 2022. Front Oncol. 2022. PMID: 36059663 Free PMC article.
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer.
Buonaiuto R, Napolitano F, Parola S, De Placido P, Forestieri V, Pecoraro G, Servetto A, Formisano L, Formisano P, Giuliano M, Arpino G, De Placido S, De Angelis C. Buonaiuto R, et al. Among authors: giuliano m. Biomolecules. 2022 Sep 29;12(10):1394. doi: 10.3390/biom12101394. Biomolecules. 2022. PMID: 36291602 Free PMC article. Review.
Ribociclib in newly diagnosed hepatitis B infection: A case report.
Di Costanzo F, Carrano S, Iengo G, Cefaliello A, Cossiga V, Morisco F, Giuliano M, De Angelis C, Arpino G. Di Costanzo F, et al. Among authors: giuliano m. Front Oncol. 2023 Jun 8;13:1184952. doi: 10.3389/fonc.2023.1184952. eCollection 2023. Front Oncol. 2023. PMID: 37361578 Free PMC article.
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors.
Pietroluongo E, De Placido P, Tortora M, Martinelli C, Viggiano A, Saponaro MR, Caltavituro A, Buonaiuto R, Morra R, Ottaviano M, Del Deo V, Cernera G, Gelzo M, Malfitano AM, Di Tolla MF, De Angelis C, Arpino G, Terracciano D, Bianco R, Veneziani BM, Formisano P, Castaldo G, Palmieri G, De Placido S, Giuliano M. Pietroluongo E, et al. Among authors: giuliano m. J Thorac Oncol. 2023 Oct;18(10):1399-1407. doi: 10.1016/j.jtho.2023.06.015. Epub 2023 Jun 28. J Thorac Oncol. 2023. PMID: 37390981 Free PMC article.
REThinking the role of the RET oncogene in breast cancer.
Di Grazia G, Conti C, Nucera S, Motta G, Martorana F, Stella S, Massimino M, Giuliano M, Vigneri P. Di Grazia G, et al. Among authors: giuliano m. Front Oncol. 2024 Aug 1;14:1427228. doi: 10.3389/fonc.2024.1427228. eCollection 2024. Front Oncol. 2024. PMID: 39211557 Free PMC article. Review.
Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type.
Buonaiuto R, Neola G, Caltavituro A, Longobardi A, Mangiacotti FP, Cefaliello A, Lamia MR, Pepe F, Ventriglia J, Malapelle U, Troncone G, Giuliano M, Arpino G, Pignata S, De Angelis C. Buonaiuto R, et al. Among authors: giuliano m. Front Oncol. 2024 Sep 9;14:1412807. doi: 10.3389/fonc.2024.1412807. eCollection 2024. Front Oncol. 2024. PMID: 39314634 Free PMC article.
549 results